retatrutide clinical trial spain New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats: • Phase 2 Trial of Retatrutide

On the Ground GLP-1s are everywhere right now, and pharmacies are feeling it, from retail to specialty to weight-loss-focused clinics

Our RDNs help you optimize results, reduce side effects & meet nutrition needs

I asked the doctor if I could be put in a coma until it was over.

Even when patients use popular anti-obesity drugs with strong weight-loss effects, they can still reach a plateau where further weight loss stops

Michigan's largest health insurer, Blue Cross Blue Shield of Michigan, is stopping coverage for glucagon-like peptide-1 (GLP-1) drugs used for weight loss starting in January 2025

Some people taking tirzepatide report increased sensitivity to cold temperatures